Increased Expression of Inactive Rhomboid Protein 2 in Circulating Monocytes after Acute Myocardial Infarction

J Cardiovasc Transl Res. 2024 Oct;17(5):1059-1066. doi: 10.1007/s12265-024-10519-5. Epub 2024 May 14.

Abstract

Increased TNF-α levels following acute myocardial infarction (AMI) contribute to impaired recovery of myocardial function. Interaction of inactive rhomboid protein 2 (iRhom2) with TNF-α converting enzyme (TACE) is required for TNF-α shedding from immune cells. We hypothesized that iRhom2 expression increases in circulating monocytes following AMI. Transcript levels of iRhom2, TACE and TNF-α were evaluated by quantitative real-time PCR in isolated monocytes of 50 AMI patients at admission (d1) and 3 days (d3) after. We observed a significant increase in levels of iRhom2 mRNA expression in monocytes between d1-3, while TNF-α and TACE mRNA expression remained unchanged. At d3, iRhom2 mRNA expression positively correlated with levels of intermediate monocytes or serum TNF-α, and negatively with LV systolic function. iRhom2 may contribute to regulation of post-infarction inflammation and is associated with LV dysfunction following AMI. iRhom2 modulation should be evaluated as a potential therapeutic strategy to attenuate cardiac remodeling following AMI.

Keywords: Heart failure; Inflammation; Myocardial infarction; TNF-alpha; Ventricular remodeling; iRhom2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM17 Protein* / genetics
  • ADAM17 Protein* / metabolism
  • Aged
  • Carrier Proteins / blood
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Male
  • Middle Aged
  • Monocytes* / metabolism
  • Myocardial Infarction / blood
  • Myocardial Infarction / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Time Factors
  • Tumor Necrosis Factor-alpha* / blood
  • Tumor Necrosis Factor-alpha* / genetics
  • Tumor Necrosis Factor-alpha* / metabolism
  • Up-Regulation*
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / genetics
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left*
  • Ventricular Remodeling

Substances

  • ADAM17 Protein
  • Tumor Necrosis Factor-alpha
  • ADAM17 protein, human
  • RNA, Messenger
  • RHBDF2 protein, human
  • Carrier Proteins
  • TNF protein, human
  • Intracellular Signaling Peptides and Proteins